Analysis of the Burden and Changing Trends of Nonalcoholic Fatty Liver Disease in China from 1990 to 2021.

Q4 Medicine
Jun Tang, Nan Zheng, Yu-Xin Yan, Nan Zhang, Xiao-Mei Ren
{"title":"Analysis of the Burden and Changing Trends of Nonalcoholic Fatty Liver Disease in China from 1990 to 2021.","authors":"Jun Tang, Nan Zheng, Yu-Xin Yan, Nan Zhang, Xiao-Mei Ren","doi":"10.3881/j.issn.1000-503X.16339","DOIUrl":null,"url":null,"abstract":"<p><p>Objective To analyze the trend of disease burden changes in non-alcoholic fatty liver disease(NAFLD)in China from 1990 to 2021,and provide a basis for formulating prevention and treatment strategies.Methods The standardized incidence rate,prevalence,mortality and disability adjusted life year(DALY)rate of NAFLD in China from 1990 to 2021 in the Global Burden of Disease Study 2021 were extracted.The average annual percentage change of the rate was calculated by Joinpoint 4.2 and the age,period and birth cohort effects of the prevalence and DALY rate were analyzed by age-period-cohort model.Results Since 1990,the incidence rate and prevalence of NAFLD have been on the rise,while the mortality and DALY have been on the decline.The age effect of disease incidence and DALY rate shows an upward trend followed by a downward trend for both males and females.The period effect is based on the period from 1992 to 1996 as the reference group,and the overall trend of the disease incidence period effect curve shows a downward trend followed by an upward trend,with the period from 2002 to 2006 being the lowest point(RR=0.93).The period effect curves of DALY showed a downward trend from 1992 to 2011,and then tended to flatten out.The birth cohort effect was used as the reference group from 1972 to 1981,and the incidence rate showed a steady upward trend in the general population,male and female populations.The DALY rate showed an overall upward trend followed by a downward trend,with the peak occurring in the birth cohort group between 1922 and 1931.The DALY rate of NAFLD caused by smoking and high fasting blood glucose has shown a downward trend since 2014,and fasting blood glucose gradually becomes the dominant factor with age.Conclusions The prevalence of NAFLD in China has been on the rise from 1990 to 2021,but the DALY rate has significantly decreased.This suggests that current prevention and control strategies are effective,and further efforts should be made to raise residents' health awareness and control the occurrence and development of NAFLD.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国医学科学院学报","FirstCategoryId":"1087","ListUrlMain":"https://doi.org/10.3881/j.issn.1000-503X.16339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To analyze the trend of disease burden changes in non-alcoholic fatty liver disease(NAFLD)in China from 1990 to 2021,and provide a basis for formulating prevention and treatment strategies.Methods The standardized incidence rate,prevalence,mortality and disability adjusted life year(DALY)rate of NAFLD in China from 1990 to 2021 in the Global Burden of Disease Study 2021 were extracted.The average annual percentage change of the rate was calculated by Joinpoint 4.2 and the age,period and birth cohort effects of the prevalence and DALY rate were analyzed by age-period-cohort model.Results Since 1990,the incidence rate and prevalence of NAFLD have been on the rise,while the mortality and DALY have been on the decline.The age effect of disease incidence and DALY rate shows an upward trend followed by a downward trend for both males and females.The period effect is based on the period from 1992 to 1996 as the reference group,and the overall trend of the disease incidence period effect curve shows a downward trend followed by an upward trend,with the period from 2002 to 2006 being the lowest point(RR=0.93).The period effect curves of DALY showed a downward trend from 1992 to 2011,and then tended to flatten out.The birth cohort effect was used as the reference group from 1972 to 1981,and the incidence rate showed a steady upward trend in the general population,male and female populations.The DALY rate showed an overall upward trend followed by a downward trend,with the peak occurring in the birth cohort group between 1922 and 1931.The DALY rate of NAFLD caused by smoking and high fasting blood glucose has shown a downward trend since 2014,and fasting blood glucose gradually becomes the dominant factor with age.Conclusions The prevalence of NAFLD in China has been on the rise from 1990 to 2021,but the DALY rate has significantly decreased.This suggests that current prevention and control strategies are effective,and further efforts should be made to raise residents' health awareness and control the occurrence and development of NAFLD.

1990 - 2021年中国非酒精性脂肪肝负担及变化趋势分析
目的分析1990 - 2021年中国非酒精性脂肪性肝病(NAFLD)疾病负担变化趋势,为制定防治策略提供依据。方法提取《2021年全球疾病负担研究》1990 - 2021年中国NAFLD标准化发病率、患病率、死亡率和伤残调整生命年(DALY)率。采用joinpoint4.2计算患病率的年平均变化百分比,采用年龄-时期-队列模型分析患病率和DALY率的年龄、时期和出生队列效应。结果1990年以来,NAFLD的发病率和患病率呈上升趋势,死亡率和DALY呈下降趋势。男性和女性疾病发病率和DALY率的年龄效应均呈现先上升后下降的趋势。时期效应以1992 - 1996年为参照组,疾病发病时期效应曲线总体趋势呈现先下降后上升的趋势,2002 - 2006年为最低点(RR=0.93)。从1992年到2011年,DALY的周期效应曲线呈现下降趋势,之后趋于平缓。1972 - 1981年以出生队列效应作为参照组,在普通人群、男性和女性人群中发病率均呈稳定上升趋势。DALY率总体呈先上升后下降的趋势,1922年至1931年出生队列组达到峰值。吸烟和空腹高血糖所致NAFLD的DALY率自2014年以来呈下降趋势,且随着年龄增长,空腹血糖逐渐成为主导因素。结论1990 - 2021年,中国NAFLD患病率呈上升趋势,但DALY率明显下降。提示目前的防控策略是有效的,应进一步提高居民的健康意识,控制NAFLD的发生发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中国医学科学院学报
中国医学科学院学报 Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
6813
期刊介绍: Acta Academiae Medicinae Sinicae was founded in February 1979. It is a comprehensive medical academic journal published in China and abroad, supervised by the Ministry of Health of the People's Republic of China and sponsored by the Chinese Academy of Medical Sciences and Peking Union Medical College. The journal mainly reports the latest research results, work progress and dynamics in the fields of basic medicine, clinical medicine, pharmacy, preventive medicine, biomedicine, medical teaching and research, aiming to promote the exchange of medical information and improve the academic level of medicine. At present, the journal has been included in 10 famous foreign retrieval systems and their databases [Medline (PubMed online version), Elsevier, EMBASE, CA, WPRIM, ExtraMED, IC, JST, UPD and EBSCO-ASP]; and has been included in important domestic retrieval systems and databases [China Science Citation Database (Documentation and Information Center of the Chinese Academy of Sciences), China Core Journals Overview (Peking University Library), China Science and Technology Paper Statistical Source Database (China Science and Technology Core Journals) (China Institute of Scientific and Technological Information), China Science and Technology Journal Paper and Citation Database (China Institute of Scientific and Technological Information)].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信